Login

PERNIX THERAPEUTICS HOLDINGS, INC. 3 SEC Filings

Filed On Filing
12 Feb 2018 Form 3: Smith Angus W., SVP, Chief Bus Off & PFO

Holds 3,300 shares of Common Stock

08 Dec 2017 Form 3: Whaley Glenn, Inter VP Fin, POA & Controller

Holds 1,100 shares of Common Stock

17 Nov 2017 Form 3: Leone John R, Director

No securities owned

17 Nov 2017 Form 3: Swirsky Douglas J, Director

No securities owned

17 Jan 2017 Form 3: Pina Kenneth, Sen VP, Counsel, Comp Off

No securities owned

22 Nov 2016 Form 3: Leung Gabriel, Director

Holds 0 shares of No securities are beneficially owned.

08 Nov 2016 Form 3: Langer Dennis, Director

Holds 0 shares of No securities are beneficially owned.

01 Aug 2016 Form 3: Miao Graham G, President and CFO

Holds 0 shares of No securities are beneficially owned

19 Aug 2015 Form 3: Siegel Barry J, Senior VP and General Counsel
01 Jun 2015 Form 3: Golembiewski Michael Joseph, VP Finance, Controller, CAO

No securities owned

24 Jun 2014 Form 3: Patel Sanjay S, Chief Financial Officer

No securities owned

29 Apr 2014 Form 3: Konidaris Tasos, Director

No securities owned

19 Mar 2014 Form 3: Shalaby Rick, SVP Sales and Marketing

No securities owned

14 Mar 2014 Form 3: Sedor John A, Director

No securities owned

11 Mar 2014 Form 3: Novak Terence, Chief Operating Officer

No securities owned

07 Feb 2014 Form 3: Drysdale Douglas, Director

No securities owned

20 May 2013 Form 3: Clifford Tracy Simmons, VP of Accounting

Holds 22,563 shares of Common Stock

23 Apr 2013 Form 3: Dorsey Brian, SVP, Research

Holds 13,538 shares of Common Stock

01 Feb 2012 Form 3: Elms Steve, Director

Holds 2,000,000 shares of Common Stock

13 Dec 2011 Form 3: Hrushka Charles S, VP of Sales and Marketing

Holds 0 shares of No securities are beneficially owned.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support